BAP1 Loss Defines a Pathologically Aggressive Subgroup of Clear Cell Renal Cell Carcinoma

被引：0

作者：

Kapur, P. ^{[1
]}

Christie, A. ^{[1
]}

Pena-Llopis, S. ^{[1
]}

Margulis, V. ^{[1
]}

Lotan, Y. ^{[1
]}

Xie, X-J ^{[1
]}

Brugarolas, J. ^{[1
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

LABORATORY INVESTIGATION | 2013年 / 93卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

926

引用

页码：223A / 223A

页数：1

共 50 条

[21] A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
Farley, Megan N.
Schmidt, Laura S.
Mester, Jessica L.
Pena-Llopis, Samuel
Pavia-Jimenez, Andrea
Christie, Alana
Vocke, Cathy D.
Ricketts, Christopher J.
Peterson, James
Middelton, Lindsay
Kinch, Lisa
Grishin, Nick
Merino, Maria J.
Metwalli, Adam R.
Xing, Chao
Xie, Xian-Jin
Dahia, Patricia L. M.
Eng, Charis
Linehan, W. Marston
Brugarolas, James
MOLECULAR CANCER RESEARCH, 2013, 11 (09) : 1061 - 1071
[22] Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma
da Costa, Walter Henriques
da Cunha, Isabela Werneck
Fares, Aline Fusco
Bezerra, Stephania M.
Shultz, Luciana
Clavijo, Diego Abreu
da Silva, Deusdedit Vieira
Netto, George Jabboure
Guimaraes, Gustavo Cardoso
Zequi, Stenio de Cassio
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) : 243.e1 - 243.e8
[23] Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma
da Costa, Walter Henriques
Fares, Aline Fusco
Bezerra, Stephania M.
Morini, Mariana A.
de Toledo Benigno, Ligia Alencar
Clavijo, Diego Abreu
Fornazieri, Lucas
Rocha, Mauricio Murce
da Cunha, Isabela Werneck
Zequi, Stenio de Cassio
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (01) : 78 - 85
[24] Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
Feng, Zhan
Zhang, Lixia
Qi, Zhong
Shen, Qijun
Hu, Zhengyu
Chen, Feng
FRONTIERS IN ONCOLOGY, 2020, 10
[25] BAP1 Immunohistochemistry Predicts Outcomes in a Multi-Institutional Cohort with Clear Cell Renal Cell Carcinoma
Kapur, Payal
Christie, Alana
Raman, Jay D.
Then, Matthew T.
Nuhn, Philipp
Buchner, Alexander
Bastian, Patrick
Seitz, Christian
Shariat, Shahrokh F.
Bensalah, Karim
Rioux-Leclercq, Nathalie
Xie, Xian-Jin
Lotan, Yair
Margulis, Vitaly
Brugarolas, James
JOURNAL OF UROLOGY, 2014, 191 (03): : 603 - 610
[26] Loss of BAP1 Protein Expression Is an Independent Marker of Poor Prognosis in Patients With Low-Risk Clear Cell Renal Cell Carcinoma
Joseph, Richard W.
Kapur, Payal
Serie, Daniel J.
Eckel-Passow, Jeanette E.
Parasramka, Mansi
Ho, Thai
Cheville, John C.
Frenkel, Eugene
Rakheja, Dinesh
Brugarolas, James
Parker, Alexander
CANCER, 2014, 120 (07) : 1059 - 1067
[27] A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
Ge, Yu-Zheng
Xu, Lu-Wei
Zhou, Chang-Cheng
Lu, Tian-Ze
Yao, Wen-Tao
Wu, Ran
Zhao, You-Cai
Xu, Xiao
Hu, Zhi-Kai
Wang, Min
Yang, Xiao-Bing
Zhou, Liu-Hua
Zhong, Bing
Xu, Zheng
Li, Wen-Cheng
Zhu, Jia-Geng
Jia, Rui-Peng
JOURNAL OF CANCER, 2017, 8 (13): : 2643 - 2652
[28] Concomitant Loss of PBRM1 and BAP1 Protein Expression is an Important Prognostic Event in Early Stages of Clear Cell Renal Cell Carcinoma
da Cunha, Isabela W.
da Costa, Walter H.
Fares, Aline F.
Bezerra, Stephania M.
Schultz, Luciana
Guimaraes, Gustavo C.
Zequi, Stenio C.
LABORATORY INVESTIGATION, 2018, 98 : 336 - 336
[29] Loss of BAP1 and PBRM1 protein expression and its association with clear cell renal cell carcinoma-specific survival.
Joseph, Richard Wayne
Kapur, Payal
Serie, Daniel
Eckel-Passow, Jeanette
Thai Huu Ho
Brugarolas, James
Parker, Alexander S.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[30] PBRM1 and BAP1 expression in renal cell carcinoma
Kuthi, L.
Fallmann, E.
Jenei, A.
Posfai, B.
Maraz, A.
VIRCHOWS ARCHIV, 2018, 473 : S44 - S44

← 1 2 3 4 5 →